Related Experiment Video
Updated: Oct 14, 2025

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Patterns of Replacement Fibrosis in Hypertrophic Cardiomyopathy
Jie Liu1, Shihua Zhao1, Shiqin Yu1
1From the State Key Laboratory of Cardiovascular Disease (J.L., Y.Z., J.W.), MR Center (S.Z., S.Y., L.L., J.S.), Cardiomyopathy Ward (G.W., D.W., L.K., L.S.), and National Clinical Research Center for Cardiovascular Diseases (L.S.), Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, 167, Beilishilu, Xicheng District, 100037 Beijing, China.
Insights
In hypertrophic cardiomyopathy (HCM), myocardial replacement fibrosis is unevenly distributed and weakly linked to heart muscle thickening. Greater fibrosis extent predicts a worse prognosis, irrespective of location.
Area of Science:
- Cardiology
- Medical Imaging
- Genetics
Background:
- Myocardial replacement fibrosis is a key feature of hypertrophic cardiomyopathy (HCM).
- Its precise characteristics and prognostic significance remain incompletely understood.
Purpose of the Study:
- To characterize myocardial replacement fibrosis in HCM using cardiac MRI.
- To assess the prognostic value of fibrosis extent and distribution.
Main Methods:
- Prospective study of 798 patients with HCM undergoing contrast-enhanced cardiac MRI.
- Analysis of global and 16-segment late gadolinium enhancement (LGE) extent.
- Primary endpoint: all-cause death.
Main Results:
- Fibrosis (LGE) showed weak correlation with left ventricular wall thickness.
- LGE distribution was inhomogeneous and asymmetric, concentrated in basal and mid-ventricular septal and anterior regions.
- Both global and regional LGE extent were associated with increased risk of death.
Conclusions:
- Myocardial replacement fibrosis in HCM is inhomogeneous, asymmetric, and weakly correlated with hypertrophy.
- The extent of fibrosis, regardless of location, is a significant predictor of adverse outcomes in HCM.
Abstract:
Background Myocardial replacement fibrosis is one of the major histologic features of hypertrophic cardiomyopathy (HCM), but its characteristics have not been well delineated. Purpose To clarify the characteristics of replacement fibrosis in HCM and to evaluate the prognostic value of the regional extent of fibrosis. Materials and Methods This prospective study evaluated participants with HCM who underwent contrast-enhanced cardiac MRI from March 2011 to April 2019. For each participant, global and 16-segment extent of late gadolinium enhancement (LGE) in the left ventricle (LV) at cardiac MRI was analyzed. The primary end point was all-cause death. Results Among the 798 study participants enrolled (median age, 49 years [interquartile range {IQR}: 38-59 years]; 508 men), 588 (74%) underwent whole-exome sequencing. Thirty-five participants (4%) experienced death from any cause during a median follow-up of 2.9 years (IQR: 1.5-4.7 years). Spearman analysis showed weak correlations between the extent of LGE and wall thickness (LGE of global LV and maximal LV wall thickness, r = 0.35 [P < .001]; LGE and thickness of septum, r = 0.30 [P < .001]). In the 16-segment model, the distribution of LGE was visually inhomogeneous and higher in the basal anterior, basal septal, midanterior, and midseptal regions (P < .001). This similar distribution of LGE was observed in participants with asymmetric septal hypertrophy, those with apical HCM, participants positive for mutation and those negative for mutation, and participants with MYH7 and MYBPC3 mutations. Cox analysis indicated that both the global extent of LGE (adjusted hazard ratio = 1.68 per 10% increase in LGE; P < .001) and the regional extent of LGE (ie, basal, midventricular, and apical regions of LV when on the short-axis view; septum, anterior free wall, inferior free wall, and lateral free wall when on the long-axis view) were associated with adverse outcomes. Conclusion In hypertrophic cardiomyopathy, myocardial replacement fibrosis weakly correlated with hypertrophy, was inhomogeneous and asymmetric, and was predominantly distributed in the interventricular septal wall and anterior free wall at the basal and mid levels. Greater extent of fibrosis was associated with poor prognosis, regardless of its location in the left ventricle. © RSNA, 2021 See also the editorial by Hanneman in this issue.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure II: Pathophysiology
Myocarditis I: Introduction
Cardiomyopathy I: Introduction and Classification
Rheumatic Heart Disease I: Introduction
Cardiomyopathy IV: Restrictive Cardiomyopathy

